Cargando…
Plitidepsin for the management of a cancer patient infected with SARS-CoV-2 while receiving chemotherapy
Autores principales: | Guisado-Vasco, P., González-Cortijo, L., D'Errico, G., Serrera-Alvarez, A., Sotres-Fernandez, G., García-Coca, M., Fernández-Sousa, J.M., Luepke-Estefan, X.E., López-Martín, J.A., Jimeno, J.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260503/ https://www.ncbi.nlm.nih.gov/pubmed/34242743 http://dx.doi.org/10.1016/j.annonc.2021.07.003 |
Ejemplares similares
-
Plitidepsin as a successful rescue treatment for prolonged viral SARS-CoV-2 replication in a patient with previous anti-CD20 monoclonal antibody-mediated B cell depletion and chronic lymphocytic leukemia
por: Guisado-Vasco, P., et al.
Publicado: (2022) -
Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19
por: Varona, Jose F, et al.
Publicado: (2022) -
Plitidepsin for multiple myeloma
Publicado: (2019) -
Plitidepsin in adult patients with COVID-19 requiring hospital admission: A long-term follow-up analysis
por: Varona, Jose F., et al.
Publicado: (2023) -
Antitumor activity of lurbinectedin in combination with oral capecitabine in patients with metastatic breast cancer
por: Awada, A.H., et al.
Publicado: (2022)